top of page

Knowledge Center

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Patient Stories

Advancing Targeted Cancer Therapy Selection Through Liquid Biopsy | Dr. Gilberto Lopes

Patient Stories

Dec 19, 2025

Advancing Targeted Cancer Therapy Selection Through Liquid Biopsy | Dr. Gilberto Lopes

Read More
Advancing Targeted Cancer Therapy Selection Through Liquid Biopsy | Dr. Gilberto Lopes

Publications

Clinical utility of cerebrospinal fluid (CSF) circulating tumour DNA (ctDNA) next generation sequencing (NGS) for diagnosis and treatment of leptomeningeal metastasis (LM) in patients with non-small cell lung cancer (NSCLC): a multi-centre retrospective study

Publications

Dec 1, 2025

Clinical utility of cerebrospinal fluid (CSF) circulating tumour DNA (ctDNA) next generation sequencing (NGS) for diagnosis and treatment of leptomeningeal metastasis (LM) in patients with non-small cell lung cancer (NSCLC): a multi-centre retrospective study

Read More
Clinical utility of cerebrospinal fluid (CSF) circulating tumour DNA (ctDNA) next generation sequencing (NGS) for diagnosis and treatment of leptomeningeal metastasis (LM) in patients with non-small cell lung cancer (NSCLC): a multi-centre retrospective study
High clinical actionability of a pan-cancer tissue-based combined DNA and RNA next generation sequencing assay in a diverse Asian population

Publications

Nov 13, 2025

High clinical actionability of a pan-cancer tissue-based combined DNA and RNA next generation sequencing assay in a diverse Asian population

Read More
High clinical actionability of a pan-cancer tissue-based combined DNA and RNA next generation sequencing assay in a diverse Asian population
Predictive Model for Mortality Risk Stratification Using Laboratory Biomarkers in Singaporeans

Publications

Nov 12, 2025

Predictive Model for Mortality Risk
Stratification Using Laboratory
Biomarkers in Singaporeans

Read More
Predictive Model for Mortality Risk Stratification Using Laboratory Biomarkers in Singaporeans

News & Updates

Why Dr Eric Topol Calls CHIP a Primary Cardiovascular Risk Driver

News & Updates

Mar 18, 2026

Why Dr Eric Topol Calls CHIP a Primary Cardiovascular Risk Driver

Read More
Add
Lucence, DxD Hub and NCCS Launch S$6M Research Collaboration to Advance Cancer Diagnostics Through AI and Patient-Centric Research

News & Updates

Mar 13, 2026

Lucence, DxD Hub and NCCS Launch S$6M Research Collaboration to Advance Cancer Diagnostics Through AI and Patient-Centric Research

Read More
Add
Lucence and Partners Pathology Collaborate to Advance Cancer Diagnostics in Malaysia

News & Updates

Mar 5, 2026

Lucence and Partners Pathology Collaborate to Advance Cancer Diagnostics in Malaysia

Read More
Add

Webinars

Mayo Clinic Laboratories: The next generation of liquid biopsy testing

Webinars

Nov 12, 2025

Mayo Clinic Laboratories: The next generation of liquid biopsy testing

Visit
Mayo Clinic Laboratories: The next generation of liquid biopsy testing
New Frontiers in Liquid Biopsy for Lung Cancer

Webinars

Jun 30, 2021

New Frontiers in Liquid Biopsy for Lung Cancer

Read More
New Frontiers in Liquid Biopsy for Lung Cancer

Case Studies

LiquidHALLMARK® ctRNA Detects ALK Fusion in Lung Cancer

Case Studies

Nov 12, 2025

LiquidHALLMARK® ctRNA Detects ALK Fusion in Lung Cancer

Read More
LiquidHALLMARK® ctRNA Detects ALK Fusion in Lung Cancer
bottom of page